ClinicalTrials.gg
Sign In

Radiculopathy clinical trials

The registry lists 483 studies for Radiculopathy across more than 10 countries. 145 are recruiting or about to start. 344 of them are mainly about Radiculopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Radiculopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
221
Recruiting
80
Not yet recruiting
52
Status unknown
50
Terminated
27
Active, not recruiting
24

Phase

Phase 2
26
Phase 3
24
Phase 4
15
Phase 1
9
Early Phase 1
3

Where

United States
126
Pakistan
72
Turkey
59
Egypt
48
Korea, Republic of
16
China
15

Who runs them

Riphah International University (43) · Cairo University (33) · Marmara University (18) · Johns Hopkins University (8) · October 6 University (6) · Foundation University Islamabad (6) · University of Lahore (6) · Providence Medical Technology, Inc. (5)

What is being tested here

Drugs under test in Radiculopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone206
Triamcinolone113
Cannabis sativa subsp. indica TOP101
Triamcinolone Acetonide012
Acetaminophen002
Bupivacaine012
Methylprednisolone012
Pentoxifylline001
Glucose001
Sodium Chloride001

Drug classes tested here Corticosteroids 2 open · Local anesthetics 4

Coming up

2phase 3 studies under way
41studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 80 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 49 (61%) stop at 75 or younger. 3 (4%) take children under 18. 0 (0%) are for women only and 1 (1%) for men only; 7 (9%) take healthy volunteers.

Recruiting studies that take each age, of 80
AgeWomenMen
103 (4%)3 (4%)
1847 (59%)47 (59%)
3067 (84%)67 (84%)
4078 (98%)79 (99%)
5074 (93%)75 (94%)
6553 (66%)53 (66%)
7537 (46%)37 (46%)
8525 (31%)25 (31%)

Across all 483 studies, recruiting or not: 61% stop at 75 or younger and 45% at 65; 3% take children; 1% are for women only and 1% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Radiculopathy studies take

Of 215 interventional studies with no phase under Radiculopathy, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo5–45 · 215 studies—11 mo5–30 · 203 studies
Observational75 mo26–95 · 40 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Newly registered9

Show 4 more

Studies

Recruiting first, then most recently updated. Showing 50 of 483. Browse all 483 → or search them.